Reasons of variation in sentinel node biopsy in patients with ductal carcinoma in situ

Vet, S.A.L. de (2016) Reasons of variation in sentinel node biopsy in patients with ductal carcinoma in situ.

[img] PDF
Restricted to Restricted

2MB
Abstract:Ductal Carcinoma In Situ (DCIS) is non a invasive breast cancer. Between 14-53% of DCIS may develop into invasive breast cancer in a period of ten years. In most cases DCIS will be treated like invasive breast cancer. The treatment of DCIS is mastectomy or breast conserving surgery, consisting of microscopically complete tumor excision and radiotherapy. Moreover a sentinel node biopsy can be applied. Different studies shows that there is nationwide variation in the use of sentinel node biopsy in patients with biopsy DCIS. To reach consensus about this issue to provide adequate care and to avoid unnecessary treatment, it is necessary to get clear which parameters have influence on the usage of sentinel node biopsy. The aim of this study is to research the causes of the observed variation and logics involved. The overall research question is ‘What are the reasons for the observed variation in the use of sentinel node procedure in patients with biopsy DCIS according to breast surgeons?’
Item Type:Essay (Master)
Faculty:TNW: Science and Technology
Subject:44 medicine
Programme:Health Sciences MSc (66851)
Link to this item:http://purl.utwente.nl/essays/71604
Export this item as:BibTeX
EndNote
HTML Citation
Reference Manager

 

Repository Staff Only: item control page